Research Topics
| Qiaoyi ZhangSummaryAffiliation: Merck Research Laboratories Country: USA Publications
| Collaborators
|
Detail Information
Publications
Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitisMike Thomas
Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen, United Kingdom
Pediatrics 115:129-34. 2005..A unified treatment strategy for asthma and allergic rhinitis, as recommended by the Allergic Rhinitis and Its Impact on Asthma initiative, might reduce the costs of treating these conditions...
Treatment and outcomes in patients with asthma and allergic rhinitis in the United kingdomQiaoyi Zhang
Merck and Co, Whitehouse Station, NJ 08889 0100, USA
Int Arch Allergy Immunol 142:318-28. 2007..Since allergic rhinitis in asthma patients is associated with worse asthma control, the treatment of the comorbid condition may improve outcomes...
Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) studyHyo Soo Kim
Seoul National University Hospital, Seoul, South Korea
Curr Med Res Opin 24:1951-63. 2008..Data on achieving National Cholesterol Education Program Adult Treatment Panel III (ATP III) goals in Asia are limited...
Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record databaseQiaoyi Zhang
Global Health Outcomes, Merck Sharp and Dohme Corp, One Merck Drive, Whitehouse Station, NJ 08889 0100, USA
Adv Ther 27:223-32. 2010..This study examined differences in baseline characteristics between patients with type 2 diabetes initiating sitagliptin vs. exenatide treatment in clinical practice settings in the US...
Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysisRobert W Dal Negro
Bussolengo Gen Hospital, Verona, Italy
BMC Pulm Med 9:10. 2009....
Compliance and persistence with concomitant statin and oral antihyperglycemic therapyQiaoyi Zhang
Global Health Outcomes, Merck Sharp and Dohme Corp, Whitehouse Station, NJ 08889, USA
Am J Manag Care 17:746-52. 2011..To compare compliance and persistence with statin and oral antihyperglycemic therapies in patients with type 2 diabetes who received concomitant therapy. Study Design: Retrospective cohort study using a large US commercial claims database...
Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record databaseQiaoyi Zhang
Merck Sharp and Dohme Corp, Global Health Outcomes, Whitehouse Station, NJ 08889 0100, USA
Curr Med Res Opin 26:1697-703. 2010....
Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patientsKimberly G Brodovicz
Merck Sharp and Dohme Corp, Whitehouse Station, NJ, USA
Curr Med Res Opin 29:101-7. 2013..To assess the impact of hypoglycemia on clinical outcomes among hospitalized, insulin-treated patients...
Suboptimal persistence with inhaled corticosteroid monotherapy among children with persistent asthma in the UKQiaoyi Zhang
Global Health Outcomes, Merck and Co, Inc, Whitehouse Station, NJ, USA
Prim Care Respir J 20:97-101. 2011..Long-term studies indicate that adherence to asthma controller therapy decreases over time, and persistence with therapy may be poor...
Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysisSteven Han
Merck Sharp and Dohme Corp, Whitehouse Station, NJ, USA
Curr Med Res Opin 28:969-77. 2012..To compare effects of fixed-dosed combinations (FDCs) and coadministered dual therapy (CDT) of antihyperglycemic agents on glycemic control (i.e., HbA(1c)) and medication adherence...
Physician reasons for nonpharmacologic treatment of hyperglycemia in older patients newly diagnosed with type 2 diabetes mellitusElizabeth Marrett
Global Health Outcomes, WS2E85, 1 Merck Drive, Whitehouse Station, NJ, 08889, USA
Diabetes Ther 3:5. 2012..To identify reasons why primary care physicians (PCPs) do not treat older patients newly diagnosed with type 2 diabetes mellitus (T2DM) with antihyperglycemic agents following diagnosis...
Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey studyQiaoyi Zhang
Merck Sharp and Dohme Corp, Whitehouse Station, NJ USA
BMC Endocr Disord 11:17. 2011..abstract:..
Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey studyElizabeth Marrett
Global Health Outcomes, Merck Sharp and Dohme, Corp, Whitehouse Station, NJ, USA
BMC Res Notes 4:251. 2011..abstract:..
Maternal anaemia and preterm birth: a prospective cohort studyQiaoyi Zhang
Merck and Co, Inc, Whitehouse Station, NJ, USA
Int J Epidemiol 38:1380-9. 2009..We examined if maternal anaemia exposure both within and across trimesters during gestation is associated with preterm birth...
